ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

Ford Named Acting CORB Chief; Hunter CCOP Coordinator

July 10, 1987

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

October 7, 1994

Crawford Testimony in 2002 Promised Job to Pazdur.

February 18, 2005

House Committee Adds $73 Million To President’s NCI Budget, Only $13 Million Under Senate Figure

August 3, 1984

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

UT System Chancellor to Travel to MD Anderson After Faculty Senate Survey Finds Plunging Morale

September 6, 2013